This PK-PD model allows for mathematical simulations, produces testable predictions, and has implications for the study of deferiprone and ciclopirox as inhibitors of eIF5A hydroxylation in other clinical conditions known to involve hypusine formation, such as cancer [128–131] and parasitic diseases (e.g. [132,133]). The gene discussed is EIF5A; the disease is cancer.